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Use of Dendritic Cells (DC) Genetically Modi®ed by ALVAC Vectors Carrying MAGE
Sequences to Induce Antimelanoma Immune Responses
M. Trakatelli, M. Toungouz, P. van der Bruggen, M. Lambermont, T. Velu, M. Heenen, and C.
Bruyns
Free University, Brussels, Belgium
DC are highly ef®cient antigen presenting cells. Due to their capacity to induce primary immune
responses, vaccination with DC genetically modi®ed to express tumor-associated antigens holds
the promise for successful cancer immunotherapy. DC gene delivery is most ef®ciently achieved by
viral vectors. ALVAC viral vector was derived by Institut MeÂrieux (France) from a highly
attenuated canarypox virus that does not replicate in mammalian cells. The safety and ef®ciency of
ALVAC recombinant vectors to induce protective immune responses to their inserted foreign
genes have been validated in humans within diverse infectious diseases trials or cancer trials. We
generated DC from adherent blood monocytes from melanoma patients enrolled in ongoing
clinical trials of vaccination (at Erasme Hospital) and infected them with a recombinant ALVAC
virus encoding either a marker gene (EGFP) or the MAGE 1 and 3 minigenes. The aims of this
study were to ®rstly evaluate the ef®ciency of DC transduction by ALVAC vectors, then to
investigate if such infection induced or not their maturation and ®nally to control if MAGE-
transduced DC were able to activate MAGE-speci®c CTLs clones. 5% to 60% (according to the
patient-donor) of immature DC were successfully infected by ALVAC vectors as shown by EGFP
expression. Flow cytometry analysis of surface markers expressed on DC after ALVAC infection
did not reveal a mature phenotype when compared to control noninfected DC tested at the same
day. But most importantly, our results demonstrated that DC from HLA-A1 patient-donors
transduced with ALVAC vectors carrying MAGE 1/3 minigenes were capable of activating a
MAGE 3/A1 CTL clone more ef®ciently than same DC loaded with MAGE 3/A1 peptide, as
shown by increased IFN-g secretion. These results could be the basis for the development of a new
strategy in melanoma immunotherapy.
002
Elastin Peptides Up-Regulate proMMP-2 Activation and Melanoma Cells Migration
Through Three-Dimensional Type I Collagen Matrix
C. Ntayi, W. Hornebeck,* and P. Bernard
Department of Dermatology, CNRS FRE 2260; IFR 53-Biomolecules, Faculty of medicine, REIMS;
*Department of Biochemistry, CNRS FRE 2260; IFR 53-Biomolecules, Faculty of medicine, REIMS
Elastin, as a main constituent of elastin ®bers, plays a prominent role in skin biology. Its enzymic
degradation by gelatinases (MMP-2, MMP-9) leads to the liberation of elastin peptides (E.P.)
which exhibit several biological functions. Particularly, interaction between E.P. and a truncated b
galactosidase elastin/laminin receptor present at the plasma membrane of various cell types was
shown to trigger MMP-expression (Brassart et al, J Biol Chem 2000).
We here evidenced that elastin peptides (50±200 mg per ml) from organo-alkaline or elastase
hydrolyses of insoluble elastin could stimulate MMP-2, but not MMP-1, expression from highly
tumorigenic melanoma cells, in a dose-dependant manner. When those cells were grown within
type I collagen gels, in presence of EDPs, MMP-2 activation was strikingly exacerbated, an effect
probably resulting from elastin-mediated MT1-MMP increased expression (Brassart et al, Clin Exp
Metastasis 1998). Parallely, invasion of type I collagen matrix by melanoma cells was signi®cantly
increased.
This preliminary investigation, in keeping with our previous data (Capon et al, Clin Exp
Metastasis 1999), indicate that the main ®brillar matrix macromolecules of human dermis i.e
collagen and elastin actively contribute to tissue invasion, through modulation of MMPs expression
and activation, by melanoma cells.
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Identi®cation by cDNA Microarray Technology of Genes Modulated by UV-B in
Normal Human Melanocytes
C. Valery, J. J. Grob, and P. Verrando
LIMP, UniversiteÂ de la MeÂditeÂrraneÂe, Marseille, France
Although it is known that solar UV-B radiations play a major role in melanogenesis and
melanocarcinogenesis, a list of function-related genes involved in such cutaneous stress response is
lacking. By using the DNA microarray technology, this study characterized target genes of the
UV-B stress response in normal human melanocytes, the pigment-synthesizing skin cells.
Expression of more than 9000 genes was simultaneously checked 4 h after irradiation of the cells at
100 mJ per cm2. 198 genes have a modulation factor > 1.9 times. Among them, 159 corresponded
to DNA known sequences, the encoded proteins being mostly in DNA- or RNA- binding/
synthesis/modi®cations or ribosomal proteins. The others were transcription factors, receptors,
tumors suppressors and (pro)oncogenes. Furthermore, 39 DNA sequences corresponded to
unknown genes (``Expressed Sequence Tag'', EST) were also modulated. In order to identify new
genes of UV-B stress, two of them were primarily selected. Their kinetics of expression following
UV-B stress were characterised by RT-PCR con®rming the DNA microarray data. Furthermore,
mRNA of these ESTs were always found expressed in melanoma cell lines at differents levels. In
return, they were not found in melanoma tumors at different stages. The 5¢ end of one of this EST
was ampli®ed by primer extension (5¢ RACE). The sequencing of this ®rst ampli®cation product
showed an Alu element. This study, that established an expression pro®les of melanocytic genes
collectively modulated by UV-B stress allows to identify new proteins and genes that could
represent new markers of UV-B induced melanocarcinogenesis.
004
The POH-1 Subunit of Proteasome is Involved in UVB DNA Damages Repair in
Melanocytic Cells
V. Pellier, C. Valery, M. DeMeÂo, J. J. Grob, and P. Verrando
LIMP, UniversiteÂ de la MeÂditeÂrraneÂe, Marseille, France; Laboratoire de BiogeÂnotoxicologie et MutageÂneÁse
Environnementale EA 7030, FaculteÂ de Pharmacie, Marseille, France
UVB radiations induce great amount of DNA damaged bases which are potentialy responsible for
cutaneous carcinogenesis. Recent studies show that the proteasome is involved in DNA excision
repair. The aim of this study was to evaluate implications of proteasome on DNA repair and cell
resistance of normal and transformed human melanocytes exposed to an UVB stress. The
phamacological inhibition of proteasic activity of the proteasome (ALLN and Lactacystin) causes
de®cient repair of cyclobutan-pyrimidin dimers (CPD) in cultured cells exposed to a 40 mJ per cm2
UVB dose. In return, instrumental overexpression in melanoma cells of the POH-1 subunit of 19S
proteasome leads to a better cells survival toward increased UV doses (0±250 mJ per cm2). A
speeding up to 25% of UVB-induced CPD repair is also observed. The presence of ALLN in
cultured medium of cells overexpressing POH-1 maintains repair de®ciency, suggesting that
ALLN is able to reverse the effet of POH-1. An UVB irradiation of 100 mJ per cm2 modi®es
POH-1 ARNm levels on a 24-h period of time. Taken together, the results show that a proteasic
activity of proteasome and a POH-1 dependent activity are together involved in UVB-induced
DNA damages repair in human melanocytes cells. These results open new phamacoloical
perspectives in the ®eld of the modulation of cutaneous melanocytes resistance to UVB stress and
its possible alteration in melanocarcinogenesis.
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GM3 Ganglioside of Human Melanoma Tumors Contains a Lactonized Sialic that is a
Ligand of Interleukin-4
I. Popa, J. P. Zanetta,* J. Portoukalian, and L. Thomas
Laboratory of Tumor Glycobiology, INSERM U.346, Faculty of Medicine Lyon-Sud, University Lyon-I,
69921 Oullins Cx, France; *Laboratory of Biological Chemistry, University of Sciences and Technologies of
Lille, 56955 Villeneuve d'Ascq Cx, France
The gangliosides of human melanoma tumors have structures different from those of gangliosides
of normal melanocytes. Whereas the latter cells contain mostly GM3, the transformed melanocytes
display a more complex pro®le with GM3, GM2, GD3 and GD2. These gangliosides, that are
considered as markers of malignant melanoma, are shed into the extracellular medium during
proliferation of malignant melanocytes. They can be the taken up by monocytes and disturb their
biological activity. We have shown the presence of de-N-acetyl neuraminic acid in GD3
ganglioside, while this sialic acid is always N-acetylated in normal tissues. Moreover, we have
shown that the sialic acid of GM3 ganglioside is mostly in the form of an internal lactone 1±7
which has just been reported to be a ligand of interleukin-4 (Cebo et al, J Biol Chem 2001,
276:5685±5691). The binding of interleukin-4 produced by activated leucocytes on GM3 that is
present in high concentrations on malignant melanocytes is likely to disturb the activity of the
immune system in the vicinity of the tumors.
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Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell
Immunoglobulin-Like Receptor
M. Bagot, A. Moretta, S. Sivori, R. Biassoni, C. Cantoni, C. Bottino, L. Boumsell, and A.
Bensussan
INSERM U448 and Service de Dermatologie de l'hopital Henri Mondor, Creteil, France; Dipartimento di
Medicina Sperimentale, UniversitaÁ di Genova, Genova, and Istituto Nazionale per la Ricerca sul Cancro,
Genova, Italy
The tumor cells of patients with cutaneous T cell lymphomas (CTCL) have the cell surface
phenotype of mature T helper lymphocytes and may be impossible to differentiate from non
malignant lymphocytes, both in skin and blood. Until now, no speci®c cell membrane marker of
CTCL has been reported. In the present study, we report for the ®rst time that CTCL cells express
the MHC class I binding p140/killer cell immunoglobulin-like receptor which has been described
on a minor subset of NK lymphocyte and on a marginal circulating CD8+ T lymphocyte subset.
Interestingly, the molecular characterization of this KIR expressed by CTCL allowed us to isolate a
novel allelic form of p140/KIR3DL, resulting in four amino acid substitutions, three in the
extracellular immunoglobulin-like domain of the protein and one in the cytoplasmic region. This
®nding is likely to be an important new issue, both for the pathophysiology and for the clinical
management of CTCL patients (Blood, 1 March 2001, 97, in press).
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Cutaneous T Cell Lymphoma Cells Express a Novel Early Activation Surface Membrane
Receptor
M. Bagot, M. Nikolova, A. Tawab, A. Marie-Cardine, L. Boumsell, and A. Bensussan
INSERM 448 and Service de Dermatologie, HoÃpital Henri Mondor, 94010 CreÂteil, France
Using a newly generated monoclonal antibody (mAb), we identi®ed the 96 kDa transmembrane
receptor SC5 expressed simultaneously on a human Sezary cell line and a minor T cell subset in
normal individuals. SC5 antigen was detected mostly on CD45RO+ lymphocytes from both
CD4+ and CD8+ subsets as well as on NK and B lineage cells. SC5 surface expression increased
very early after polyclonal stimulation of CD3+ cells due to the transfer of intracellular SC5
molecules to the cell membrane. Engagement of SC5 receptor by its mAb inhibited the anti-CD3-
induced proliferation and cytokine secretion of peripheral blood T cells and cell clones, while, SC5
mAb did not affect the cytotoxic activity of CD8+ T cell clones. Extensive phenotypic analysis
revealed that the percentage of SC5+CD4+ circulating lymphocytes in SS patients was
signi®cantly increased in comparison with controls (p < 0.001) and correlated with the
morphologically detected percentage of SS cells in peripheral blood (p < 0.001). In one patient
we clearly demonstrated that the circulating malignant T cells coexpresses SC5 molecules.
Importantly, ligation of SC5 receptor in a cutaneous T cell lymphoma (CTCL) cell line profoundly
inhibited the anti-CD3 induced proliferation. Consequently, the expression of SC5 receptor in SS
patients peripheral blood may serve not only to detect the presence of circulating malignant CD4+
cells but also a target for immunotherapy (J Invest Dermatol, 2001, in press).
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Decreased Expression of Fas (Apo-1/Cd95) on Lesional CD4+ T Lymphocytes in
Cutaneous T Cell Lymphomas: Correlations with Blood Data
O. Dereure, P. Portales, J. Clot, and J. J. Guilhou
CHRU Montpellier
Background: In a previous work, we demonstrated that the expression of apoptosis-mediating
membrane receptor Fas/APO-1/CD95 was signi®cantly decreased on CD4+ peripheral blood
cells in CTCL compared with benign cutaneous lymphocytic in®ltrates, which may favour the
hypothesis of an initial accumulation of lymphocytes by a defective T-cell postactivation apoptosis.
However, it is unknown whether skin-in®ltrating lymphocytes displayed the same phenotype
consistent with a defective Fas-dependent apoptosis.
Material and methods: Study by ¯ow cytometry of fas expression on lesional CD4+ T cells
extracted from cutaneous lesions of 12 patients with mycosis fungoides and 11 apparied patients
with lymphocytic cutaneous benign in¯ammatory disorders; comparison with fas expression on
CD4+ peripheral blood cells collected the same day.
Results: This study con®rmed that fas expression on peripheral CD4+ lymphocytes was
signi®cantly lower in patients with CTCL and demonstrated that lesional lymphoid cells showed
a similar pattern. Furthermore, correlation of Fas/CD95 expression between skin and blood
lymphocytes appeared to be good.
Conclusion: These data support the hypothesis of an impaired Fas-mediated T cell apoptosis in
CTCL physiopathology and establish additional correlations between blood and skin-based data in
MF as to immunophenotyping pro®le of lymphocytes.
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Inhibition of CGRP Expression in Alopecia Areata
D. Meyronet, K. Jaber,* A. Gentil-Perret, F. Cambazard, and L. Misery*
Departments of Pathology and *Dermatology, University Hospital, Saint-Etienne, France
The course of alopecia areata appears to be associated to stress. Denervation allows hair to grow
again. Hence, the nervous system is involved in the pathophysiogeny of this disease.
Fifteen outpatients with alopecia areata have undergone biopsies of healthy scalp and lesions. We
have searched for the expression of substance P and CGRP (calcitonin gene-related peptide),
which are neurotransmitters coexpressed by sensitive nervous ®bres. This immunohistochemical
study has been performed on freezed slides. Monoclonal antibodies were revealed by
immunoperoxidase.
Substance P was expressed in a same manner in healthy scalp and lesions. On the contrary,
CGRP was strongly expressed on basal cells of epidermis and hairy folicles in healthy scalp whereas
it was almost undetectable in lesions of alopecia areata.
This dramatic inhibition of CGRP expression could be due to a decrease of production or to a
diminished expression of CGRP receptor. A recent study reveals a strong decrease of CGRP blood
amounts. CGRP is a neurotransmitter with vasodilatator and immunosuppressive properties. We
suggest the inhibition of CGRP expression in lesions favours vasoconstriction and the effects of
lymphocytes, which are known to induce alopecia areata patches. Hence, CGRP agonists could be
used to treat this disease. Works about other neurotransmitters are in process.
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Drug Speci®c Cytotoxic T-Lymphocytes in the Skin Lesions of a Patient with Toxic
Epidermal Necrolysis (TEN)
A. Nassif, A. Bensussan, G. DorotheÂe, F. Mami-Chouaib, N. Bachot, M. Bagot, L. Boumsell, and
J.-C. Roujeau
UniteÂ INSERM U 448 et Service de Dermatologie, HoÃpital H. Mondor, UniversiteÂ Paris XII, CreÂteil,
France
Objective: To characterize the T-lymphocytes present in the skin and suspect of being the
effectors of the reaction in TEN, a drug reaction with widespread apoptosis of keratinocytes,
considered to result from Fas±FasLigand interaction.
Methods: In a patient suffering from cotrimoxazole induced TEN, blister ¯uid cells were
phenotyped by FACS and tested without any prior restimulation for cytotoxicity on autologous
and allogeneic cells in the presence of the drug.
Results: Blister ¯uid cells were homogeneous for a phenotype of CD8+, DR+, CLA+,
CD56+ T-lymphocytes and expressed preferentially two Vb chains of the TCR repertoire. These
lymphocytes were cytotoxic towards autologous EBV transformed lymphocytes and towards
allogeneic cells sharing HLA-Cw4. Cytotoxicity occurred only in the presence of either
cotrimoxazole or sulfamethoxazole but not with the hydroxylamine metabolite of sulfamethox-
azole. The lysis was blocked by an anti-MHC Class I monoclonal antibody. It was abolished by
EGTA, but neither by antifas nor by anti-TRAIL monoclonal antibodies, suggesting perforin/
granzyme mediated cytotoxicity, without implication of fas at this stage.
Conclusions: This is the ®rst direct evidence that T-lymphocytes present within the lesions of
TEN may exhibit, without any re-stimulation, a drug-speci®c cytotoxicity against autologous cells.
Harboring the markers of classical CTLs with MHC Class I restriction these lymphocytes reacted
against the parent drug and not against its main reactive metabolite. These results challenge several
current concepts and, if con®rmed in further patients, could support new therapies.
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Expression of High Af®nity Immunoglobulin E Receptor (FceRI) on Mast Cells
Increases the Intensity of the In¯ammatory Response in a Model of Atopic Dermatitis
(AD)
D. Staumont-SalleÂ,*² E. Delaporte,* M. Capron,² and D. Dombrowicz²
*Department of Dermatology, CHRU, Lille, France; ²INSERM U167, Institut Pasteur, Lille, France
The pathogenesis of AD still remains unclear, but FceRI is thought to be involved in the early and
late stages of this disease. To con®rm the potential role of FceRI, we performed epicutaneous
sensitization with ovalbumin of wild-type mice (BALB/c), with FceRI expression restricted to
mast cells and basophils, of FceRI-de®cient mice (FceRIa±/±) and of transgenic mice, expressing a
humanized FceRI (hFceRIa Tg) with a cell distribution similar to that in humans. The results
obtained for BALB/c and FceRIa±/± mice suggest that FceRI expression on mast cells increases
the intensity of the cutaneous and IgE responses, directly modulates mast cells recruitment to skin
and lymph nodes and indirectly modulates cutaneous recruitment of eosinophils and antigen-
presenting cells. On the other hand, the humanized cell distribution of FceRI does not enhance the
immune response in this model. Furthermore, following a strictly cutaneous sensitization, we
observed an in¯ammatory response in the lungs from the three groups of animals, correlating with
the extent of skin in¯ammation. Works are in progress in order to study cytokines and chemokines
released upon FceRI activation.
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HIV Infection of a Reconstructed Mucosa Integrating Langerhans Cells
P. Sivard, O. DeleÂzay, J. Kanitakis,* J.-F. Mosnier,² C. Genin, and L. Misery
`Group Mucosal Immunity and Pathogen Agents', ²Department of Pathology, University of Saint-Etienne;
*Department of Dermatology, Edouard Herriot Hospital, Lyon, France
We have performed a reconstructed in vitro mucosa integrating Langerhans cells (LC), and we have
investigated the infection by HIV-1 of this model.
The epithelium consists of vaginal keratinocytes cultured on de-epidermized dermis in
submerged medium for two weeks. LC precursors, obtained by differentiation of CD34+ cord
blood progenitor cells in presence of GM-CSF, TNF-a, TGF-b and Flt3L, are added in the
reconstructed epithelium after 4±6 days of culture. Immuno-histochemical and ultrastructural
studies showed that LC were detected in a physiological location in the well-strati®ed,
differentiated epithelium.
HIV-1 strains (LAI and BaL) were added 1° on a epithelium of vaginal cells, 2° on isolated fresh
LC, and 3° on the model of reconstructed mucosa. By nested PCR, we have shown the presence
of proviral DNA in cultured LC and in LC integrated in reconstituted vaginal mucosa. In contrast,
we could not detect any HIV-1 proviral DNA in epithelial cells. Then, we concluded that, in our
experiments, only LC were infected by HIV isolates in this vaginal epithelial model. This one
seems to be a useful tool for studying the mechanisms involved in heterosexual transmission of
HIV.
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In Freshly Isolated Human Langerhans Cells CD1a Molecules are Spontaneously
Internalized, Gain Access to the Endosomal Pathway and Recycle to the Cell Surface
D. Lipsker, J. Salamero,* H. Bausinger,² A. M. Mommaas, D. Spehner, F. Proamer, J.-P.
Cazenave,³ B. Goud,* H. de la Salle, and D. Hanau
INSERM E 99±08 et ³U 311, ETS, 67065 Strasbourg, France; *UMR 144, Institut Curie, 75248
Paris, France et ²Departement de Dermatologie et Centre de Microscopie Electronique, LUMC, Leiden,
Hollande.
The cytoplasmic tail of CD1a molecules does not contain any of the targeting motifs known to
direct membrane proteins into clathrin-coated pits and vesicles. In this study, we showed that in
freshly isolated human Langerhans cells (LCs) CD1a molecules are not only present ± at steady state
± on the cell surface but also inside the cells, where they colocalized weakly with intracellular
MHC class II molecules and with late endosomal/lysosomal markers. Immunoelectron
microscopic analysis of ultrathin cryosections revealed the spontaneous presence of CD1a in
clathrin-coated pits and vesicles as well as in Birbeck granules. Incubating freshly isolated LCs with
an anti-CD1a FITC-labeled mAb con®rmed the capacity of LCs (1) to internalize spontaneously
CD1a molecules (2) the rapid localization of CD1a in early endosomes and (3) the recycling of
CD1a from early endosomes to the cell surface. When endocytosis was blocked with latrunculin A
or cytochalasin D, we observed (1) increased CD1a cell surface expression (2) the absence of CD1a
from the Rab11+ recycling endosomal compartments and (3) an enhanced capacity of LCs to
stimulate a CD1a restricted T-cell clone.
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Antagonist Effect of IL-4 and TGFb1 on Langerhans Cell-Related Antigen Expression by
Human Monocytes
G. Guironnet, C. Dezutter Dambuyant, C. Vincent, D. Schmitt, and J. PeÂguet-Navarro
INSERM U346, HoÃpital E. Herriot, Pavillon R, Lyon, France
In this study we analyzed the speci®c effects of TGF-aÃ1 and/or IL-4 on monocyte-derived cells.
To this end, monocytes were cultured with either GM-CSF, GM-CSF/TGF-aÃ1, GM-CSF/IL-4
or GM-CSF/IL-4/TGF-aÃ1 before cell morphology, phenotype and function were assessed. As
expected, IL-4 is mandatory for monocyte differentiation into potent allostimulatory dendritic
cells. In its absence, monocyte-derived cells share many phenotypic and functional features with
macrophages, such as CD14, CD16, CD64 and CD71 expression and lack of allostimulatory
function. Interestingly, however, the cells express E-cadherin, independently of exogenous TGF-
aÃ1. Most importantly, a subset of monocytes cultured with GM-CSF/TGF-aÃ1 expresses Langerin,
as assessed by ¯ow cytometry and con®rmed by electron microscopy analysis. Langerin
engagement with speci®c monoclonal antibody induces its internalization in coated pits and
coated vesicles and the formation of typical Birbeck granules. Monocytes cultured in GM-CSF/IL-
4 neither express E-cadherin nor Langerin. The simultaneous addition of TGF-aÃ1 allows most of
the cells to express E-cadherin but rarely Langerin, Taken together, the results add further evidence
that LC can derive from monocytes and demonstrate an antagonistic effect of IL-4 and TGF-aÃ1 on
monocyte differentiation towards the LC pathway.
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Germline and Somatic Mutations of the INK4a-ARF Gene in a XP-C Patient
N. Sou®r, M. Rybojad,* T. Magnaldo,³ O. Thibaudeau, L. Daya-Grosjean,³ J. Rivet,² A.
Sarasin,³ and N. Basset-Seguin
U532, IRP *Service de Dermatologie, ²Service d'Anatomie pathologique, HoÃpital Saint-Louis, Paris;
³UPR42,CNRS Vilejuif, France
Xeroderma pigmentosum of group C (XP-C) is an inheritable autosomal recessive disease
characterized by a defect in global genome repair, leading to the development of multiple skin
tumours. A high proportion of these tumors harbor UV induced mutations (i.e. double CC > TT
tandem transitions) of the p53 and/or the INK4a-ARF genes. Here, we report the clinical and
molecular features of a 12-year-old XPC patient that in addition to severe cutaneous clinical
symptoms also had 3 unusual tumors, a mediastinal lymphoblastic lymphoma, an atypical
®broxanthoma, and an epithelioid hemangioma. DNAs from eight skin tumors (4 actinic keratosis
(AK), 2 microinvasive epidermoid carcinomas (ECs), 1 basal cell carcinoma (BCC) and one
atypical ®broxanthoma) were examined by combining single strand conformation polymorphism
and direct sequencing of the p53 and INK4a-ARF genes. Two different somatic mutations of
p16INK4A were present in one tumour (a BCC) (12.5%), one of which affected also p14ARF reading
frame. The same tumour also harbored a p53 tandem mutation. In addition, the patient carried also
a germline variation affecting only the p16INK4A reading frame. This study con®rms that
simultaneous mutations of INK4a-ARF and p53 occur in some XP associated tumors.
Furthermore, we show for the ®rst time a germline variation of p16INK4A, in association with
the NER defect that could explain in part the patient's unusual phenotype.
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Assessment of Ascorbic Acid and Iron Concentrations in Psoriatic Patient Dermis vs.
Healthy Subjects
N. Leveque,* S. Robin,² P. Muret,*³ S. Mary,* S. Makki,*§ J. P. Kantelip, A. Berthelot, and Ph.
Humbert
*Laboratoire d'IngeÂnierie et de Biologie CutaneÂes, ²Laboratoire de Physiologie ³Laboratoire de Pharmacologie
Clinique, §Laboratoire de pharmacie galeÂnique, FaculteÂ de MeÂdecine et de Pharmacie, Place Saint Jacques,
25030 BesancËon cedex-France
Introduction: Reactive oxygen species (ROS) play an important role in skin in¯ammatory diseases
such as psoriasis. Iron catalysed ros formation, while ascorbic acid (AA) scavenges ROS. The aim of
this work was to assess AA and iron concentrations in involved and uninvolved psoriatic dermis
and to compare them with AA and iron levels in healthy human dermis.
Materials and methods: 10 psoriatic patients and 8 healthy subjects were enrolled in this study.
Two microdialysis probes (CMA/20) were inserted into the dermis with and without psoriatic
lesions. A parallel study using microdialysis was performed in healthy subjects. AA and iron
collected by microdialysis were assessed, respectively, by gas chromatography mass spectrometry
and atomic absorption spectrometry.
Results: AA concentrations in psoriatic dermis with and without lesions were, respectively,
38.7 6 1.6 mg per ml, 42.6 6 1.2 mg per ml. Iron levels in involved and uninvolved psoriatic dermis
were, respectively, 55.5 6 1.9 mg per l et 47.0 6 2.4 mg per l. AA and iron concentrations in
healthy dermis were, respectively, 237.4 6 8.7 mg per ml et 21.4 6 2.3 mg per l.
Conclusion: These results demonstrate that AA concentrations are lower and iron levels higher in
the dermis of psoriatic patients than in the skin of healthy subjects.
017
cDNA Cloning of Human Type I Peptidylarginine Deiminase and Expression Analysis
M. Guerrin,* A. Ishigami,² M. Sebbag,* T. Senshu,² M. Simon and G. Serre*
*Department of Biology and Pathology of the Cell, INSERM CJF 9602-IFR 30, Purpan School of
Medicine, Toulouse, France; ²Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology,
Tokyo, Japan
Deimination of cytokeratins and ®laggrin occurs in the latest stages of epidermal differentiation and
is thought to play a key role in the corni®cation process. Peptidylarginine deiminases (PADs) are a
family of enzymes that convert arginine residues to citrulline residues. This post-translational
modi®cation changes the structure and possibly the function of the protein targets.
We cloned a full length cDNA for human epidermis type I PAD by a combination of RT-PCR
using rat type I sequences, and RACE cloning. Human type I PAD displays 85% and 83%
homology with mouse and rat type I PADs, respectively. Homology with other human PADs is
more limited: 71%, 70%, 66% with type V (ortholog of mouse and rat type IV), type III, and type
II, respectively. The expression of type I PAD was analysed by RT-PCR in a panel of 17 human
tissues. In addition to epidermis, type I PAD was found to be mainly expressed in testis and
placenta, and to a lesser extent in prostate and thymus. Very low or no expression was detected in
heart, skeletal muscle, colon, small intestine, kidney, ovary, leukocytes, spleen, whole brain, lung,
liver and pancreas. Recombinant type I PAD (E. coli) encoded by the cDNA exhibited enzymatic
activity on bacterial extracts. Antisera elicited in rabbits are being used to determine the precise
location of type I PAD in human epidermis.
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Homophilic Interactions of Human Corneodesmosin
C. Caubet, S. Lawson, M. Guerrin, M. Simon, and G. Serre
Department of Biology and Pathology of the Cell, INSERM CJF 9602-IFR 30, Purpan School of
Medicine, Toulouse.
Corneodesmosin (Cdsn) is a secreted glycoprotein located in the extracellular part of
corneodesmosomes, the corneocyte-speci®c intercellular junctions. It is thought to play a major
role in stratum corneum cohesion, and its degradation at the stratum corneum surface is necessary
for desquamation to occur. Glycine- and serine-rich domains of Cdsn have been proposed to fold
as structural motifs similar to glycine loops and to confer adhesive properties to the protein.
To test if Cdsn is really an adhesive protein, and to de®ne the involved domains, full-length and
truncated Cdsn forms, GST-tagged at their terminus, were produced in E. coli and tested in vitro for
protein±protein interactions by membrane-overlay binding assays. Full-length Cdsn displayed
homophilic binding properties but did not bind to GST alone, to BSA or to ®laggrin. The
interactions were dose-dependent, and incubation with calcium only induced a moderate increase
in binding. Various forms of Cdsn deleted of the NH2- or the COOH-terminal glycine loop
domain, or of both domains, were also shown to display binding properties, but with a somewhat
lower ef®cacy in the absence of the NH2-domain. Interestingly, the full-length Cdsn and the
various deletion mutants did bind another truncated form corresponding to the NH2-terminal
domain all alone. Therefore, this domain displays adhesive properties by itself.
The results provide the ®rst experimental evidence for homophilic interactions of Cdsn, and
con®rm its involvement in intercorneocyte cohesion.
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In Vitro Interleukin-15 and Interleukin-15 Receptor Expression by Normal Human
Epidermal Keratinocytes
S. Leroy, J. Bernard, N. Chebassier,* A. C. Knol,* A. Plet, A. Godard, Y. Jacques, and B. DreÂno*
`Groupe de recherche sur les cytokines et leurs reÂcepteurs', *Laboratoire d'Immuno-Dermatologie; INSERM
U463, Nantes, France
Interleukin (IL)-15 exerts similar biological activities to IL-2, notably by permitting lymphocyte
activation.We have previously showed that IL-15 mRNA, but not IL-15 protein, could be
detected in vivo in normal epidermis. The aim of this work was to study IL-15 and IL-15 receptor
expression, and also their modulation by interferon a and aÄ, in vitro on monolayers of normal
human keratinocytes.
IL-15, IL-15RaÂ, IL-2RaÃ and aÄc mRNA expression was studied by RT-PCR, whereas IL-15
and IL-15RaÂ protein expression was examined using immunoperoxidase and Western blot.
By RT-PCR, we have observed that IL-15, IL-15RaÂ, IL-2RaÃ and aÄc mRNA were expressed by
normal human keratinocytes. IL-15 and IL-15Ra protein expression was also detected.
Interestingly, IL-15RaÂ chain was detected in the nucleus of keratinocytes. This nuclear
localization, which was con®rmed using a Western blot technique, suggests that IL-15 may play
a role at this level.
After stimulation by interferon aÂ and aÄ, we observed an increase in IL-15 and IL-15, IL-15RaÂ
and aÄc mRNA expression, respectively. IL-15 and IL-15RaÂ protein expression were increased too.
Induction of IL-15 and IL-15 receptor production in normal human keratinocytes stimulated by
IFNaÄ suggests that this cytokine could play an important role in cutaneous T cell lymphoma
development, a disease for which we previously have detected an elevated and speci®c IL-15
protein expression in keratinocytes.
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DNA Damage and UV Sensitivity of Human Keratinocytes Harboring HPV 16
S. Mouret, M. T. Leccia, S. Sauvaigo,* A. Favier, and J. C. Beani
Laboratoire de Biologie du Stress Oxydant, CHU Michallon, 38043 Grenoble cedex 03, France;
*Laboratoire des LeÂsions des Acides NucleÂiques, CEA, Grenoble, France
Human papillomaviruses (HPV) in conjunction with ultraviolet (UV) radiation may play a role in
the pathogenesis of nonmelanoma skin cancers from Epidermodysplasia verrucciformis individuals
and some immunocompromised patients. E6 and E7 oncoproteins of high risk HPV may allow
DNA damage persistence and modify UV-irradiated cells survival. The aim of our study was to
determine the effects of UV irradiations on sensitivity and DNA damage of human keratinocytes
harboring HPV 16. We used two keratinocyte lines, SKv-e and SKv-l, different in their viral
genome integration, in vitro proliferative potential, autoregulation by TNFa, and in vivo
tumorigenicity in mice. Firstly, we found signi®cant different sensitivity between the two cell lines
when exposed to a single UV irradiation. SKv-e cells with less proliferative and tumorigenicity
potential, were most sensitive to UV irradiation than SKv-l cells, lethal dose 50 corresponding,
respectively, to 0.6 and 1.5 J per cm2. This difference between the two cell lines may be correlated
with both E6 expression and p53±p21 pathway interactions. We showed secondly, using the comet
assay, no signi®cant difference between SKv-e and SKv-l cells in term of DNA strand-breaks and
alkali-labile sites. But interestingly, we found an increased of oxidative DNA damage in SKv-e
cells. In conclusion, these results suggest an interaction between viral oncoproteins and antioxidant
status, which may play an important role in HPV-infected cell transformation.
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Prevalence of Antidesmoglein Antibodies in the Tunisian Population
M. Kallel Sellami, M. Zitouni, M. Ben Ayed,* P. Martel,² D. Gilbert,² H. Masmoudi,* F. Tron,²
P. Joly,² and S. Makni
HoÃpital La Rabta, Tunis. *HoÃpital Habib Bourgiba, Sfax. ²INSERM U519, Rouen
In Tunisia, pemphigus has particular epidemiological characteristics, that mimic endemic
pemphigus in some extend. Indeed, prevalence is increased and the super®cial subtype (PF)
prevales, involving mainly young females under 35. Since anti-Dsg1 antibodies have been found in
55% healthy Brazilian people living in endemic areas we tested the hypothesis that normal subjects
living in Tunisia also have such antibodies.
Eighty four healthy blood donors from Tunis and Sfax were studied by immunoblot using an
epidermal extract and were compared with 75 Tunisian patients with pemphigus (38 PF, 34 PV, 3
pemphigus herpetiformis).
Twenty-seven percent healthy controls (22/80) had autoantibodies that recognized polypeptides
corresponding to pemphigus antigens: 15/22 reacted with a 160-kDa polypeptide (desmoglein 1),
5/22 with a 130 KD polypeptide (desmoglein 3), 8/22 with a 190-kDa polypeptide (periplakin)
and 1/22 with a 250-kDa polypeptide (desmoplakin 1). IgG1 was the predominant subtype (77%
anti-Dsg 1 antibodies, 60% anti-Dsg3 antibodies) and IgG4 subtype was never found. In contrat all
patients with autoantibodies detected by immunoblot (65% PF, 44% PV) had IgG4, sometimes
associated with other isotypes.
Anti-desmoglein antibodies and particularly anti-Dsg1 antibodies are prevalent in the Tunisian
healthy population, which may be related to the high prevalence of PF in Tunisia. Furthermore,
IgG4 are never found in healthy controls in accordance with the pathogenicity of this isotype in
pemphigus. Factors that would explain the prevalence of antidesmoglein antibodies and the switch
to pathogenic antibodies remain to be determined and probably involve both genetic background
and environmental events.
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Epistatic Interaction of DSG1 and HLA-DR4 in Pemphigus Foliaceus Susceptibility
P. Martel, D. Gilbert, M. Busson, L. Drouot, P. Joly, D. Charron, and F. Tron
INSERM U519, Rouen, France, HoÃpital Saint Louis, Paris, France
We previously described a silent single nucleotide polymorphism (SNP) of the desmoglein 1 gene
which consists of a T to C transition at position 809. To investigate the role of genetic background
in pemphigus foliaceus and to ask whether PF, like other autoimmune diseases, is expressed as a
complex trait, we simultaneously examined the role of major histocompatibility complex (MHC)
class II polymorphism and SNP(809) in PF susceptibility.
Thirty-one Caucasian French patients and 84 healthy Caucasian French controls were studied by
PCR-RFLP for SNP(809) genotyping and by PCR-SSO and PCR-SSP for DRB1 and DQB1
typing.
This analysis con®rmed involvement of DRB1*04 (p = 0.01) and DRB1*14 (p = 0.04) generics
in disease susceptibility and individualized DRB1*0102 (p = 0.04), DRB1*0402 (p = 0.02),
DRB1*0406 (0.003), and DRB1*1404 (p = 8.10±4) as susceptibility MHC class II alleles in French
PF patients. Homozygous C/C(809) genotype was also found associated with the disease
(p = 0.03). Furthermore, patients with both DRB1*04 and C/C(809) had a very signi®cant risk to
develope PF (p = 1.10±4) and comparison, by logistic regression, of susceptibility given by both risk
factors showed a signi®cant interaction between DRB1*04 and C/C(809).
DRB1*04 and C/C(809) are signi®cant risk factors to PF and interact to enhance disease
susceptibility. PF therefore constitutes another demonstrative example of the role of epistatic
interaction of individual genes in autoimmune diseases susceptibility.
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The Reconstructed Epidermis with Sensory Neurons, a New Tool to Study Dermo-
Cosmetic Products Properties
R. Steinschneider, C. Marteau,* E. Quelven, J. Franchi,* P. Andre,* and J.-C. Laurent
B.E.T. Bio Expertise Technologies, 13011 Marseille; *Laboratoires R & D ± LVMH Branche Parfums et
CosmeÂtiques, 45804 Saint Jean de Braye
Somatic sensory neurons transfer sensitive information from the skin to the Central Nervous
System. In addition, the action potential is transfered anterogradely from dentritic ®bers to the
upper epidermis. This property allows sensory neurons to deliver neuropeptides to epidermal cells,
particularly keratinocytes. The release of neuropeptides such as CGRP, substance P in skin is able
to modulate both cutaneous cell proliferation and cell differentiation and is able to regulate
secretion of both cytokines and growth factors. In order to reproduce a reconstructed sensory
epidermis we have developed a culture chamber with two compartments. Rat sensory neurons
from dorsal root ganglions were cultured on a biological matrix in the ®rst compartment. On the
other side of the matrix, in the second compartment a well-differentiated epidermis was
constructed using normal human keratinocytes. Both microscopic and immuno-enzymatic analysis
allowed us to demonstrate: i. keratinocytes have developed a pluristrati®ed epidermis; ii. cell bodies
of neurons are not directly in contact with keratinocytes; iii. Only neuritic ®bers cross the
biological matrix and establish a network among keratinocytes; iv. these cultured neurons are
mature and functional, because they spontaneously release CGRP that is over expressed when
neurons are stimulated in vitro. This novel model will be described and we will discuss potential
applications.
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Micrografts of Human Scalp Onto Nude Mice: Technical Improvement of a Human
Hair Growth Model In Vivo
M. B. de Brouwer, T. Leroy, G. Shaker, and D. Van Neste
Skinterface, Tournai, Belgium
Several sources of evidence support the use of human scalp grafts onto nude mice as a model for the
study of human hair growth ex vivo. Grafted hair follicles showed slowing down of the linear
growth rate to 2/3 of the initial value and reduction of the expected life span of the hair follicles
(up to 8 months) even though some follicles may engage into a second cycle of hair production.
Testosterone conditioning of such mice bearing samples from affected scalp sites (androgenetic
alopecia) has been proposed for assessing the ef®cacy of compounds having antiandrogen activity.
At this stage however, information on the percentage of success of graft take (in terms of grafts and
in terms of follicular units) is lacking.
In this study we performed micrografts (1±3 follicular units ± unaffected androgen non sensitive
donor site), aiming to document an eventual increase of the success rate usually obtained with the
conventional punch grafts (10±15 follicles from affected scalp sites). These ``micro'' samples were
implanted in mice and then monitored for hair growth during 7 months. Quantitative data were
obtained from phototrichograms performed every month.
The analysis of the phototrichograms showed 58.33% productive micrografts compared to the
31.1% ratio obtained from punch grafts. The number of productive follicular units in micrografts
reaches 47.22% of the initially active follicles while only 10.5% follicles remained active with the
punch graft method.
Our results suggest that the improved grafting method inspired from cosmetic scalp surgery
protocols must be further investigated as a clinically relevant experimental model.
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Evaluation of the Convenience of the CD7 Marker in the Identi®cation of Sezary Cells
A. C. Knol, N. Robillard, F. Accard, N. Chebassier, S. Leroy, M. C. Pandol®no, Y. Guilloux, F.
Jotereau, and B. DreÂno
INSERM U463 et CHU Hotel-Dieu, Nantes, France
Cutaneous T-cell lymphomas (CTCL) are characterized by the in®ltration of the skin by T
lymphocytes of the CD2+ CD3+ CD4+ CD45RO+ DR+ phenotype. CTCL represent a unique
model in tumoral terms because both tumoral and reactive cells are T lymphocytes. Till now no
speci®cal marker of tumoral cells has been described in the literature. Nevertheless, since the
idiotype of the TCR represents a unique marker for a malignant clone of T lymphocyte, the clonal
origin of tumoral cells allows us to think that the TCR-Vb clone corresponds to the tumoral cell.
Concurrently, loss of expression of CD7 is considered as a diagnostical criterium for CTCL
because of its frequent publication and would be speci®c of Sezary cells. But this hypothesis
remains uncon®rmed. Our goal is to determine whether this CD7- population represents the
Sezary cells. Our study turns on patients, cytologically con®rmed and exhibiting more than 50%
circulating Sezary cells. A sorting, by cell sorter, is realised with in order to harvest the
CD4+ CD7+ and CD4+ CD7- populations, which are then submitted to a cytological evaluation
on the basis of the cerebriform nucleus of Sezary cells. We found for our ®rst patient that both
CD4+ CD7+ and CD4+ CD7- populations contained Sezary cells, so this ®nding suggests that
CD7 is not an appropriate marker to identify Sezary cells. Moreover we were able to note that that
this cerebriform appearance was lost after a few days of in vitro culture with IL-2, IL-7 or IL-15,
therefore this aspect would be directly related to the in vivo environment.
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Expression of Retinoblastoma Gene in Melanoma Cell Line
A. Sparsa, C. BeÂdane, S. Boulinguez, H. Chable,* G. BarrieÁre,* K. Faucher,* O. Berthier-
Vergnes,* A. Varachaud,* M. Rigaud,* and J. M. Bonnetblanc
Dermatology, *Molecular Biology, CHU Dupuytren, Limoges, France
The high incidence of melanoma (4±14%) in retinoblastoma patients suggest that an
oncosuppressor gene, the retinoblastoma gene could play a role in the progression of melanoma.
Therefore we have studied the expression of retinoblastoma gene in three melanoma cell lines. Cell
culture of 3 melanoma cell lines was performed in Mac Coy 5 A medium, 5% of CO2. ARN
extraction and ampli®cation was done by RT-PCR. Western blot was performed with an
antihuman pRb monoclonal antibody (G3-245). The level of protein was quanti®ed by
spectrophotometry. We con®rm the expression of mRNA of retinoblastoma gene and of the
protein Rb in 3 new melanoma cell lines. Despite a different tumorigenicity the level of expression
of protein was identical in all cell lines and positive control MOLT-4. Thus our 3 cell lines express
Rb protein at a pre and post transcriptional level. Quantitative RT PCR could assess wether there
is or not a signi®cant difference between the cell lines and positive control. We cannot exclude the
possibility in some cell lines of a dysfunction of Rb protein secondary to mutations of other
molecules or genes (CDKN2/p16¼).
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Transduction of Melanoma Cell Lines by AAV Type 2 Vectors
S. C. Cheong, L. Tenenbaum,* C. Bruyns,* T. Velu,* and A. Brandenburger
IRIBHN, UniversiteÂ Libre de Bruxelles ± Belgium, Campus Gosselies, *Campus Erasme.
Recombinant adeno-associated virus type 2 (rAAV2) vectors are among the most promising viral
vectors for gene therapy purposes and are already being tested in clinical trials. In cancer gene
therapy the rAAV vector can be used to introduce genes that code for cytotoxic proteins into
tumour cells. In one experimental approach we propose to transduce melanoma cell lines by rAAV
vectors. However to date, the transduction ef®ciency by rAAV vectors in melanoma cells has not
been well described.
The transducibility of three human melanoma cell lines Mel.Z2, 518.A2 and EB81 was studied
by infection with rAAV-EGFP, a vector that carries the enhanced green ¯uorescent protein
reporter gene. Infection was performed at multiplicities of infection (MOI) of 2.5, 5 and 10
transducing units (TU) per cell. Two days postinfection the expression of EGFP was measured by
FACS analysis.
All three melanoma cell lines were found to be transducible by rAAV-EGFP. At an MOI of 2.5
TU/cell 10±25% of the cells were found to express EGFP. Increasing MOI resulted in over 50%
EGFP positive cells.
These results show that melanoma cell lines are transducible by rAAV2 vectors in vitro. In
contrast to most other viral vectors that require infection at high MOI, ef®cient transduction by
rAAV can be obtained at relatively low MOI, suggesting small amounts of vector may also be
suf®cient for in vivo transduction.
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Pattern of MIB-1 Distribution in Cutaneous Verrucous Carcinoma: Analysis of 5 Cases
J. C. Noel,* I. Fayt, G. De Dobbeleer, and T. Simonart
*Department of Pathology, HoÃpital Erasme, Brussels, Belgium
Introduction: Verrucous carcinoma (VC) is a low-grade squamous cell carcinoma (SCC). Its
diagnosis requires evaluation of the clinical and microscopic appearance and biologic behaviour of
the neoplasm. It is a slowly growing verrucous tumour that may ultimately penetrate deep into the
tissue. Because of its high degree of histologic differentiation, it is often not recognised as a
carcinoma for a long time. The goal of this study was to analyse the pattern of MIB-1 expression in
VC and to compare it with SCC.
Material and methods: Routinely formalin-®xed and paraf®n-embedded blocks were retrieved
from the Erasme University Hospital, Brussels, Belgium. Five cases of VC and 10 cases of invasive
well-differentiated SCC involving the skin were studied. Immunohistochemistry using MIB-1
(Immunotech, Marseille, France), a murine monoclonal antibody which reacts with the same
epitope as KI67, was carried out on 4 mm paraf®n-embedded sections using the antigen retrieval
method.
Results: In VC the positive cells were principally located in basal and suprabasal layers at the
periphery of the tubular epithelial strands. However, at the growing margin of the tumour, where
areas of cellular anaplasia and high mitotic activity were the rule, MIB-1-positive nuclei were
focally noted in intermediate layers. By contrast, in SCC, positive cells were randomly scattered
throughout the lesion.
Conclusion: This peripheral pattern of MIB-1 distribution in VC may at least partially the
differences in the clinical and morhological characteristics between VC and SCC.
029
Stromelysin 3 Expression is a Marker of Prognosis in Basal Cell Carcinomas
B. Cribier, G. Noacco, B. Peltre, and E. Grosshans
Laboratoire d'Histopathologie cutaneÂe, Clinique Dermatologique des HoÃpitaux universitaires, Strasbourg,
France
Stromelysin 3 (ST3) is a member of the metalloproteinase family, which is expressed in various
tissue remodeling processes. The prognosis of breast cancers and extracutaneous squamous cell
carcinomas is correlated to the level of expression of ST3. The purpose of this work was to study
the expression of ST3 in the 4 types of basal cell carcinomas (BCC).
We selected cases of primary BCC that were fully excised, without previous biopsy: 40 Pinkus
tumors, 40 super®cial BCC, 40 nodular BCC, 40 morpheiform BCC and 10 cases of BCC with
deep subcutaneous or muscular invasion. Immunohistochemistry was carried out using the LSAB
method, with monoclonal anti-ST3 Ab (MC Rio, IGBMC Strasbourg). A semiquantitative scale
was used to evaluate the level of ST3 expression, from 0 to 3.
Positively stained cells were restricted to the periphery of the epithelial cells, and were
concentrated around the most invasive strands. The global rate of expression was 27% of Pinkus
tumors, 65% of super®cial BCC, 72.5% of nodular BCC, 87% of morpheiform BCC and 100% of
deeply invasive BCC. In addition, the rate of BCC with intense expression of ST3 (2 or 3) was,
respectively, 7.5%, 20%, 45%, 63% and 100%.
This study con®rms that ST3 is a marker of poor prognosis, because the rate of positively stained
tumors was much higher in the aggressive BCC groups. Moreover, the majority of BCC which
intensely expressed ST3 were morpheiform BCC and tumors with deep invasion, which are both
of poor prognosis. These results are similar to those previously published in squamous cells
carcinomas and keratoacanthomas (1). Altogether, the studies on cutaneous tumors are consistent
with the theory of ST3 playing an active role in tumor progression.
(1) Asch PH et al, Am J Dermatopathol 21:146±150, 1999.
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Cutaneous Human Dendritic Cells (DCs) Express CD1d
S. Ronger, G. Guironnet, M. J. Staquet, J. Peguet, D. Schmitt, A. Claudy, and D. Jullien
UniteÂ Inserm 346, HoÃpital Edouard Herriot, Lyon
The CD1 family of cell surface glycoproteins is a third lineage of antigen presenting molecules.
Human CD1d tissular distribution is not well established. We previously reported CD1d
expression on normal human keratinocytes (NHK). In the present report, we studied CD1d
expression on cutaneous professional antigen presenting cell. Langerhans-like cells were generated
in vitro from cord blood CD34+ stem cells (GM-CSF+ TNFaÂ; 13 days) and from adherent PBMC
(GM-CSF+ IL4+ TGFaÃ = GIT; 7 days). Dermal dendrocytes like cells were differentiated from
PBMC (GM-CSF + IL4 = GI; 7 days). GI and GIT population were further matured by adding
TNFaÂ or cocultured with CD40L+ for 2 days more on the media. Immunochemistery was
performed on normal skin specimens (n = 5, mAb NOR3.2). Double staining immuno¯uores-
cence suggested that dermal dendritic cells (Factor XIIIa+, CD83+) expressed CD1d and that to a
lower level Langerhans cells (CD1a +) did too. Using speci®c primers, semiquantitative RT-PCR
was used to assess CD1d mRNA expression. In Langerhans cells generated from cord blood, time
course evaluation showed a progressive expression of CD1d mRNA. When TGFaÃ was added to
the media, CD1d mRNA expression was progressively turned off, suggesting a regulatory role for
TGFaÃ. CD1d mRNA was detected both in GI and GIT cells with a higher signal in GI population,
which support the hypothesis of an inhibitory effect for TGFaÃ. Moreover, there was an increase of
CD1d mRNA expression in these two populations during cells maturation with TNFaÂ or CD40L.
Cell surface expression was con®rmed by ¯ow cytometry on DCs developed in vitro (mAb CD1d
42.1). Our data suggest that CD1d is expressed on dermal dendrocytes and to a lower extent on
Langerhans cells. TGFaÃ inhibits the expression of CD1d mRNA, while the expression is up-
regulated when dendrocyte cells are further matured with CD40L or TNFaÂ.
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GM-CSF, TGFaÃ1 and TNFaÂ Enable Peripheral Monocytes to Become Epidermal UV-
Macrophages
N. Bechetoille, S. Dumont, V. AndreÂ,* G. Guironnet, J. PeÂguet, S. MareÂchal, D. Schmitt, E.
Perrier,* and C. Dezutter-Dambuyant
INSERM U346, Edouard Herriot Hosp., Lyon, France; *COLETICA, Gerland, Lyon, France
After acute UVB irradiation of human skin, Langerhans cells (LC) leave the epidermis. However,
the LC-depletion is transient and the epidermal compartment is rapidly colonized by CD1a±
DR+CD11b+CD36+FcaÊRII+ monocytes/macrophages. This population was called UV-
Macrophages (Meunier et al, J Invest Dermatol 1995, 105:782±788; Kremer et al, Eur J Immunol
1998, 28:2936±2946). To determine the origin of the UV-Macrophages which might either be
issued from de-differentiation of residual epidermal LC or result of a colonization by migrating
monocytes (Mo) from dermis, peripheral blood Mo were cultured in presence of 3 major
keratinocyte-derived cytokines: GM-CSF, TGFaÃ1 and TNFaÂ. After 6 days of culture with GM-
CSF and TGFaÃ1, Mo differentiated into 2 distinct CCR6+ subsets: (1) a low proportion (0.5±1%)
of CD1a+/Langerin+high/CCR6+ cells that strongly expressed the speci®c marker of LC, that is
Langerin, and (2) a high number (40±50%) of CD1a+/Langerin+low/CCR6+ cells. After addition of
TNFaÂthe Langerin+high cells increased up to 2% and kept their phenotype while the phenotype of
the Langerin+weak subset was modi®ed. The Langerin+weak population progressively acquired the
monocyte-macrophage pro®le, that is, CD1a+weak/Langerin±/CCR6+weak in presence of increasing
amounts of TNFaÂ (0±200 U/ml concentration). In presence of these 3 selected cytokines, the
peripheral blood Mo may modulate their phenotype and become very similar to epidermal UV-
Macrophages which were shown to originate from dermal monocytic cells entering epidermis after
acute UV-irradiation. The capacity of these generated UV-Macrophages-like cells to produce
IL12/IL10 and to stimulate allogeneic lymphocytes is under investigation.
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The New BDCA Markers May Clarify the Controversy Between the Lymphoid and
Myeloid Origins of the Langerhans Cells
S. Dumont, N. Bechetoille, S. MareÂchal, D. Schmitt, and C. Dezutter-Dambuyant
*INSERM UniteÂ 346, HoÃpital Edouard Herriot, Lyon, France
The lymphoõÈd vs. myeloõÈd origin of both cutaneous dendritic cells (DC), Langerhans cells (LC) and
dermal DC is still a controversial issue. The identi®cation of the new BDCA-1 to ±4 markers could
help us to solve this dilemma. We have studied the expression of these antigens on cells produced
after 7 and 14 days of culture from CD34+ progenitors in presence of GM-CSF and TNFaÂ as well
as from CD14+ monocyte-derived in presence of GM-CSF, IL4 and TGFaÃ1 for 6 days and then,
2 days by adding TNFaÂ. In both CD34+ and CD14+ systems, DC did not express BDCA2 even
though BDCA4 was expressed by the majority of cells at the different culture times. In the CD34+
system, BDCA1 (CD1c) was expressed by 20±30% of cells, this percentage increased until day 14.
In order to determine whether BDCA1 is a marker associated to an early LC differentiation stage,
double cell surface labeling was perdormed with BDCA1 and, on day 7, E-Cadherin; on day 14,
Langerine (Lang) (CD207, LC-speci®c type II lectine). On day 7, all cells were BDCA1+/E-
Cadherin+ and on day 14, two subsets BDCA1+/Lang+ and BDCA1+/Lang± were observed. In the
CD14+ system, more than 60% of cells expressed BDCA1 on day 6 as well as on day 8, even
though BDCA3 was present on more than half of the cells on day 6, BDCA3 expression was
down-regulated after TNFaÂ addition. In the CD14+ system, the strong BDCA1 expression on
Lang+ cells seems to depend on the presence of TGFaÃ1 whereas in the CD34+ system, where
TGFaÃ1 is absent, a BDCA1+ subset might not be able to acquire the LC marker. The presence of
BDCA1 (described as a myeloõÈd DC-associated marker) on DC may be correlated to their ability
to differentiate into LC. As BDCA3 expression in the CD14+ system was decreasing in parallel to
Langerin appearance, after activation by TNFaÂ, this BDCA3 marker (described as a myeloõÈd DC-
associated marker) would be present on cells which would not have yet acquired the ability to
differentiate into LC. Finally, BDCA4 (described as a plasmacytoõÈd DC-associated marker) may
reveal all cells engaged in both LC and dermal DC pathways.
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Keratinocyte Surface-Associated Proteolysis: Role in the ``In Vitro'' Shedding Process of
BP180 (Collagen XVII)
A. L. Labrousse, W. Hornebeck,* and P. Bernard
Department of Dermatology, CNRS FRE 2260, IFR 53, *Department of Biochemistry, CNRS FRE
2260, IFR 53, Faculty of medicine, REIMS
Collagen XVII (BP180) is a hemidesmosomal transmembrane protein involved in adhesion of
epithelial cells to the underlying basement membrane. It exists in two forms, including a 180-kDa
full-length transmembrane protein and a 120-kDa polypeptide, corresponding to the collagenous
ectodomain of the entire protein (SchaÈcke et al, J Biol Chem, 1998) and released as a soluble form in
culture medium of normal human keratinocyte (NHK). The purpose of this study was the in vitro
analysis of the keratinocyte surface-associated mechanisms of proteolysis that could lead to the
shedded collagen XVII, and the matrix components in¯uence on this shedding. Enhancement of
active membrane gelatinase B (MMP-9), induced by exogenous treatment with neutral
sphingomyelinase on NHK culture (Buisson et al, J Invest Dermatol, 2000), did not seem to
increase the release of the 120 kDa soluble form in culture medium. However, concomittent
treatment with sphingomyelinase and a peptide hydroxamate MMP inhibitor, batimastat,
completely inhibited the shedding. Besides, treatment of NHK with a synthetic inhibitor of
furin convertase, decanoyl-RVKR-chloromethylketone, markedly reduced the release of the
120 kDa soluble form. These data are not in favour of membrane MMP-9 involvement in the in
vitro shedding process of collagen XVII and suggest the role of a furin-dependent proteolytic
pathway. On the other hand, NHK culture on coated ¯asks, respectively, with laminin-5, laminin-
1, collagen IV and collagen I, did not modify the amount of soluble form released in culture
medium.
034
Early and Late-Stage Kaposi's Sarcoma-Derived Cells Can Invade De-epidermized
Dermis
T. Simonart, C. Degraef,³ R. Mosselmans,³ P. Hermans,§ Y. Lunardi-Iskandar,¶ J.-C. Noel,² J.-
P. Van Vooren,* D. Parent, M. Heenen, and P. Galand³
Department of Dermatology; *Department of Internal Medicine; ²Department of Pathology; ³Laboratory of
Cytology and Experimental Cancerology, Erasme University Hospital, Brussels; §Department of Infectious
Diseases, CHU St Pierre Brussels; ¶Institute of Human Virology, Baltimore, USA
Background: Whether kaposi's sarcoma (KS) is a true neoplasm or a reactive endothelial cell
outgrowth remains unclear.
Materials and methods: In this study, we investigated the differential invasive properties of
activated endothelial cells and KS cells in a model of de-epidermized dermis, supplying the cells
with matrix barriers similar to those found in vivo.
Results: Cells derived from early ``patch-stage'' and from late ``nodular-stage'' KS lesions exhibited
similar invasive properties. Low proliferation index of the cells and expression of antiapoptotic
proteins suggest that the progression of KS may be related to escape from cell death rather than to
increased proliferation. The KS-Y1 cell line, which is tumorigenic in nude mice, also exhibited
invasive properties. However, by contrast to the KS-derived spindle cells which were scattered
between the collagen bundles, the KS-Y1 cell population displayed a multilayer arrangement.
In¯ammatory cytokines and KS cell supernatant could activate and stimulate the growth of human
dermal microvascular endothelial cells but could not induce their invasion in this model.
Conclusion: These results confer to KS cells an invasive phenotype.
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Antiviral Activity of Different Anti-Herpesvirus Compounds on Keratinocyte
Organotypic Cultures Infected with Herpes Simplex Virus and Varicella-Zoster Virus
R. Snoeck, G. Andrei, E. De Clercq, and C. De Wolf-Peeters*
Rega Institute for Medical Research, *Pathology Department, U.Z., K.U.Leuven, B-3000 Leuven,
Belgium
The three-dimensional organotypic ``raft'' culture system of keratinocytes recreates important
features, both morphological and physiological, of epithelial differentiation in vitro. Human primary
keratinocytes, isolated from neonatal foreskin, grown at the air±liquid interface, stratify and
differentiate with the expression of speci®c keratins within 12±14 days. These cultures can be used
as a model for skin tissue, the main viral replication site during both primary and recurrent herpes
simplex virus (HSV) and varicella-zoster virus (VZV) infections. We have shown that infection of
cultures with HSV results in the production of cytopathic effect (CPE) independently of the stage
of differentiation of the cultures. In contrast, infection with VZV after 8±10 days of differentiation
resulted in reduced CPE compared to cultures infected after 2, 4 or 6 days of differentiation. In
order to evaluate the effect of various antiherpesvirus drugs, organotypic cultures were infected
with HSV-1 and HSV-2 after 8 days of differentiation and with VZV after 6 days of differentiation.
At the moment of infection the cultures were incubated in the presence of medium containing
different concentrations of the test compounds (acyclovir, brivudin, cidofovir and foscarnet). The
cultures were incubated for 12 days, ®xed and processed for histology. Morphological analysis of
the organotypic cultures showed that treatment with cidofovir, acyclovir and brivudin at 40, 4 and
0.4 mg per ml and foscarnet at 200 mg per ml complete protected the epithelium against virus-
induced CPE. As expected, only cidofovir and foscarnet showed activity against thymidine kinase-
de®cient viral strains. The evaluation of antiviral compounds in organotypic cultures may be of
particular interest for VZV, given the fact that there is no in vivo model for VZV.
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The aÃ-Defensin hBD-2 is Expressed in Differentiated Human Reconstructed Epidermis,
at mRNA and Peptide Levels, and is Up-Regulated in Response to Bacterial LPS
P. Chadebech, D. Goidin, C. Jacquet, J. Viac, D. Schmitt, and M. J. Staquet
INSERM U346, af®lieÂe CNRS, HoÃpital E. Herriot, Lyon, France
Defensins have been identi®ed as key elements of innate immunity against microbial infections.
Human b-defensins have been shown to be expressed in skin and airway epithelial tissues. In this
study, human b-defensin-2 (hBD-2) mRNA and peptide expression were evaluated by RT-PCR
and Western blotting in normal human keratinocytes, in function of their stage of differentiation.
In proliferating, nondifferentiating keratinocytes generated in serum-free, low-calcium medium, a
very low hBD-2 mRNA expression was found. A signi®cant higher expression was detected in
high-calcium cultivated keratinocytes grown either as monolayers or as multilayers under
submerged conditions. In reconstructed epidermis using the dead de-epidermized dermis model,
hBD-2 mRNA expression level was signi®cantly higher than in the other conditions and displayed
interindividual variability as observed in native epidermis. The protein was detected only in
reconstructed epidermis. These results indicate that hBD-2 gene expression in normal human
keratinocytes is dependent upon their stage of differentiation. Exposure of reconstructed epidermis
to bacterial lipopolysaccharide resulted in a sustained stimulation of hBD-2 gene expression
showing, for the ®rst time, at mRNA and peptide levels, the functionality of hBD-2-coding gene
in a human reconstructed skin model. These results also provide evidence that in vitro reconstructed
epidermis represents a useful model for studying regulation of expression of a-defensins after skin
challenge with pathogenic microorganisms in conditions as close as possible to the in vivo situation.
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Cell and Collagen Concentration Effect on Retracted Collagen Lattices Thickness
C. Viennet, A. Degouy, J. Bride, and P. Humbert
Engineering and Cutaneous Biology Laboratory, School of Medicine and Pharmacy F-25030 BesancËon
Introduction: In vitro dermal equivalent (also called collagen lattices) development leads to an
original model of dermal tissue. The differentiation of ®broblasts cultured in 3 dimensions in a
collagen matrix remains similar in vitro and in vivo. New technological performances in ultrasonic
imaging allow precise measurements with a good resolution. The aim of this study was to assess, by
ultrasonic imaging, the correlation between collagen lattices thickness and various collagen and cell
concentrations.
Materials and methods: 3 different concentrations of human dermal ®broblasts (F1 = 8.10
5C
per ml, F2 = 16.10
5C per ml, F3 = 32.10
5C per ml) and 3 concentrations of rat tail collagen were
prepared (C1 = 2 mg per ml, C2 = 3 mg per ml, C3 = 4 mg per ml). Collagen lattices were prepared
as follow: F2C1, F2C2, F2C3, F1C1, F2C1, and F3C1 (n = 5 per case). Ultrasonic imaging was
performed on day 0, 4, 6, 10, 12 and 14 using a Dermcupq 2020 scanner. Scans performed were
numerized to measure collagen lattices thickness in their centre and periphery.
Results: Collagen lattices echogenicity was like dermis in vivo. For each assessment, we observed
that collagen lattices thickness increases until day 12 and then stabilizes. When cellular
concentration was more important, the lattice was thicker (at day 14: F1C1 = 0.66 MM,
F2C1 = 0.86 MM, F3C1 = 1.21 mm). Collagen concentration does not in¯uence lattices thickness
signi®cantly.
Conclusion: Collagen lattices thickness increases with retraction time and cellular concentration.
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Cultured Kaposi's Sarcoma Tumor Cells Exhibit a Chemokine Receptor Repertoire that
Does Not Allow Infection by HIV-1
T. Simonart, C. Debussher, C. Liesnard,* M.-L. Delforge,* A. de Lavareille,² P. Hermans,³ J.-P.
Van Vooren,§ and P. Stordeur²
Department of Dermatology, *Virology, ²Immunology and §Internal Medicine, Erasme University Hospital,
Brussels; and ³Department of Infectious Diseases, Saint-Pierre University Hospital, Brussels, Belgium
Background: HIV-1 is known to play a critical role in the pathogenesis of AIDS-associated KS.
However, it remains controversial whether KS cells are target cells for HIV infection.
Material and methods: The expression of chemokine receptor mrna was studied by PCR in KS-
derived spindle cell cultures and in an immortalized KS cell culture (KS-Y1). To determine
whether these cells could be infected by HIV-1, we investigated the production of p24 antigen and
HIV-1 RNA after infection of the cells with the HTLVIII-B T cell tropic strain and the JRFL
macrophage tropic strain (1000 TCID50/ml).
Results: With the exception of CCR8 which is expressed by KS-derived spindle cell cultures but
not by KS-Y1 cells, unstimulated KS cells express no signi®cant levels of CD4, CCR3, CCR5 or
CXCR4. HIV infectivity assays showed that KS cells were unpermissive to HTLVIIIB and JRFL
strains, as evidenced by lack of p24 antigen and HIV RNA production as well as by absence of
HIV-1 DNA integration. Although the expression of CXCR4 mRNA could be induced by
interleukin (IL)-1b, stimulation of KS cells by this cytokine did not allow infection by HIV-1.
Conclusion: This shows that KS cells exhibit a chemokine receptor repertoire that does not allow
infection by HIV-1.
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Chemosensitivity Modulation of Melanoma with an Anti-BRCA1 Ribozyme:
Preliminary Results
C. Hesling,* M. D'Incan,*² C. D'Incan,² S. Lafarge, P. Souteyrand,² and Y. J. Bignon*
*Laboratoire d'Oncologie MoleÂculaire, Centre Jean Perrin; ²Dermatologie, CHRU, Clermont Ferrand,
France
Background: Melanoma chemoresistance is in part due to genomic mechanisms (oncogene
ampli®cation, expression of dna repair genes, expression of detoxifying enzymes).
Aim: To study melanoma cell in chemosensitivity after transfection with a zibozyme directed
against brca1 which is a gene involved in dna repair processes, cell cycle control and apoptosis.
Material and methods: Three human melanoma cell lines were tranfected with two antibrca1
ribozymes; two clones were generated in which more than 50% of brca1 expression were down
regulated. When cultivated with different drugs, cell growth (IC50) was compared between these
clones and non transfected cells and cells transfected with the tranfection vector alone.
Results: An increase of chemoresistance against paclitaxel and platinium was evidenced but no
effects with cystemustine was seen.
Comments: These preliminary results suggest that brca1 could be involved in chemoresistance of
melanoma on a way that is not yet known. Moreover, the consequence of its down regulation on
chemosensitivity seems to depend on the genotoxic drug considered.
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Differential Secretion and Activation of MMPs in Two Reconstructed Skin Models using
HaCaT or HaCaT-ras Cells
S. Holvoet, D. Nova, C. Le Griel, F. Duplan,* S. Charvat, E. Gentilhomme,² O. Damour,* D.
Schmitt, and M. Serres
Inserm U 346, HEH, Lyon, *Laboratoire des substituts cutaneÂs, HEH, Lyon, ²DeÂpartement de
Radiobiologie, C.R.S.S.A, 38702 La Tronche, France
Matrix metalloproteinases (MMPs) play an important role in tissue regeneration, wound healing
and tumor invasion. In monolayer cultures, our previous studies have shown a higher motility of
HaCaT-ras cells compared with normal human keratinocytes (NHK) or HaCaT cells correlated
with a higher secretion of MMP-2 (72 kDa) or MMP-9 (92 kDa), according to the medium used
for cell cultures. Presently, the expression and activity of MMPs were investigated in two
reconstructed skin models, using de-epidermized dermis (DED) or ®broblasts seeded in a collagen
sponge matrix. In all experiments, MMP-9 is higher secreted in HaCaT-ras cells as compared with
nontumoral keratinocytes, but its active form (86 kDa) is only detected in both reconstructed skin
models according to keratinocyte differentiation. The MMP-2 which is highly secreted by HaCaT
cells cultured in monolayer is not detected in reconstructed epidermis on DED. It is only secreted
by living ®broblasts, cultured either in collagen lattices or in a dermal substitute. However, only in
this last model, the modulation of MMP-2 secretion and activation occurred since HaCaT cells
were cultured on the dermal substitute, but not with NHK. These results suggest a direct
interaction of HaCaT with ®broblasts.
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